NASDAQ:ADVM

Adverum Biotechnologies Earning Date

USA |NASDAQ |USD

ADVM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.36 $-0.45 $-0.31
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Adverum Biotechnologies's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ADVM Earnings Date & History Chart

ADVM Earnings & Revenue Forecast

ADVM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.35 $-0.50 $-0.18
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.46 $-1.71 $-1.20
Dec 2022 5 $-1.24 $-1.57 $-0.71

ADVM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.35 $-0.36 $-0.46
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.47 $-1.48 $-1.61
Dec 2022 0 / 0 $-1.28 $-1.38 $-1.74

ADVM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $7.50M $7.50M $7.50M
Dec 2022 5 $0.00 $0.00 $0.00

ADVM Earnings Date & Revenue History

ADVM Earnings History

|
Show More
Show More

ADVM Revenue History

|
Show More
Show More

Adverum Biotechnologies Next Earnings Date & Report

ADVM Next Earnings Date & Report Preview: Sep 2021 (FQ)

ADVM's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Adverum Biotechnologies's next quarterly earnings is $-0.36, with a low EPS estimation of $-0.46, and a high estimation of $-0.24.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.37, the last 2 month trend is $-0.37, and the 3 month trend is $-0.42.

Based on 7 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Adverum Biotechnologies Previous Earnings Dates & Reports

ADVM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Adverum Biotechnologies's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ADVM's earnings per share (EPS) was $-0.45, missing the consensus analysts forecast of $-0.38 by -19.55%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 55.17%, and lower than the same period a year before (Jun 2020) by 25.00%.

Revenues were $0.00.

The company reported a net income of $-44.33M.

Free cash flow for the quarter was $-37.56M , compared to $-23.71M last quarter and $-20.02M a year before.

ADVM ended the quarter with $129.55M in total debt, an increase of 328.88% compared to the previous quarter, and an increase of 311.53% compared to the same quarter a year before.

ADVM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Adverum Biotechnologies's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

ADVM's earnings per share (EPS) was $-1.37, missing the consensus analysts forecast of $-1.31 by 4.58% , and lower than the previous year's EPS (Dec 2019) by 37.00%.

Revenues were $0.00.

The company reported a net income of $-117.51M.

Adverum Biotechnologies reported a free cash flow of $-91.14M for its fiscal year, compared to $-68.42M a year ago.

The company ended the fiscal year with $30.71M in total debt, a decrease of -4.78% compared to the previous year.